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Abstract
Spinal muscular atrophy (SMA) is a major genetic cause of death in childhood characterized by marked muscle weakness. To
investigate mechanisms underlying motor impairment in SMA, we examined the spinal and neuromuscular circuitry
governing hindlimb ambulatory behavior in SMA model mice (SMND7). In the neuromuscular circuitry, we found that nearly
all neuromuscular junctions (NMJs) in hindlimb muscles of SMND7 mice remained fully innervated at the disease end stage
and were capable of eliciting muscle contraction, despite a modest reduction in quantal content. In the spinal circuitry, we
observed a ,28% loss of synapses onto spinal motoneurons in the lateral column of lumbar segments 3–5, and a significant
reduction in proprioceptive sensory neurons, which may contribute to the 50% reduction in vesicular glutamate transporter
1(VGLUT1)-positive synapses onto SMND7 motoneurons. In addition, there was an increase in the association of activated
microglia with SMND7 motoneurons. Together, our results present a novel concept that synaptic defects occur at multiple
levels of the spinal and neuromuscular circuitry in SMND7 mice, and that proprioceptive spinal synapses could be a
potential target for SMA therapy.
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Introduction
Spinal muscular atrophy (SMA), a leading genetic cause of
infant mortality, is an autosomal recessive motoneuron disease
characterized by spinal motoneuron loss, muscle atrophy and
motor impairment [1,2]. This disease is caused by deletion or
mutation of the survival of motor neuron 1 (SMN1) gene and low
expression of the SMN protein derived from the closely-related
SMN2 gene, and as such the disease severity is determined by
SMN2 gene copy numbers. Although SMN protein plays diverse
roles in RNA metabolism and is expressed ubiquitously through-
out the body, deficiency in SMN protein affects primarily the
motor system in SMA [3]. Recent studies using various animal
models have greatly expanded our understanding of SMA at the
cellular and molecular levels [4]. However, the cellular basis and
pathogenesis of motor impairment in SMA remain unclear [5].
One proposed idea is that motor impairment in SMA may
result from motoneuron loss and peripheral denervation. In a
widely used SMA mouse model (SMND7) that recapitulates many
symptoms of human SMA, denervation (,7–15%) is indeed
identified in a few proximal muscles, such as the paraspinal and
intercostal muscles when motoneuron loss is modest at the end
stage [6,7,8]. However, no denervation is observed in a wide range
of major limb muscles [6,9]. Thus, it remains intriguing why the
ambulatory function is impaired. In addressing the structural and
functional integrity of neuromuscular junctions (NMJs), recent
studies reported NMJ pathologies, such as neurofilament accu-
mulation and immature endplate morphology, as well as a
reduction in quantal release in SMND7 mice [6,8,9,10]. However,
given the high safety factor at the NMJ [11], it is unclear whether
the reduction of transmitter release would be severe enough to
cause neuromuscular transmission failure and muscle weakness in
the non-denervated muscle targets in SMND7 mice. Thus, further
functional analyses of the NMJ and muscle contraction in SMND7
mice would resolve the role of NMJs in muscle weakness.
Besides the NMJ and muscles, motor behavior is also governed
by neural circuits in the spinal cord, where motoneurons receive
synaptic inputs from local interneurons, descending pathways and
proprioceptive sensory neurons. The convergence of proper
excitatory and inhibitory inputs onto motoneurons is required
for motor control, reflexes and tonic firing of the motoneurons.
Disruption of the cellular components and/or connectivity in this
spinal circuitry has been implicated in the motoneuron disease
[12,13,14]. However, little is known about the synaptic connec-
tivity in the SMA spinal cord, and whether or not the loss of
central synapses participates in the pathogenesis of SMA is an
open question.
Given the emerging concept that many neurodegenerative
diseases involve synaptopathy [15], it is crucial to study synapses at
multiple levels of the spinal and neuromuscular circuitry in SMA.
In the current study, we used SMND7 mice to examine the
synaptic circuitry controlling hindlimb muscles responsible for
ambulatory function, which is compromised in both patients and
mice [16,17]. We showed that NMJs at the SMND7 hindlimb,
despite being structurally and functionally altered, were capable of
eliciting muscle contraction upon nerve stimulation. In addition,
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column of lumbar segments 3–5 were significantly reduced in
mutant mice. The novel concept that SMA is a disease involving
central, in addition to peripheral, synaptopathy may lead to new
therapeutic approaches that work to enhance synapse formation
and function in the spinal cord.
The preliminary results of this study have been presented
(K.K.Y.L., M.Y.L., C.P.K. 2007 Society for neuroscience meeting
abstract. #488.7; 2008 Society for neuroscience meeting abstract.
#643.6).
Results
NMJs in SMND7 hindlimb muscles are fully innervated
throughout the disease progression
Prior to addressing whether a defect in neuromuscular function
contributes to motor impairment, it is essential to examine the
innervation pattern of NMJs in major hindlimb muscles in SMND7
mice.Tofacilitatetheobservationofthenerve terminals,wecrossed
a mouse line that overexpresses yellow fluorescent protein (YFP) in
motoneurons [18] with the SMND7 mouse line. Similar to the
original SMND7 mouse line [19], the SMND7/YFP mice displayed
progressive muscle weakness with a life span of ,14 days. We
labeled perisynaptic Schwann cells (PSCs) with anti-S100 antibody
and postsynaptic acetylcholine receptors (AChRs) with a-bungaro-
toxin to examine the tripartite arrangement of the NMJ [20].
Throughout disease progression (postnatal day 1–14), we found that
nearly all NMJs in the extensor digitorum longus (EDL) muscle of
SMND7 mice, as in non-SMA control littermates (i.e. littermates
that carry homozygous/heterozygous mouse Smn alleles), were fully
innervated (Fig. 1A and 1B). Even at the end-stage, we observed
only an insignificant number of NMJs that were denervated (control
vs. SMND7: total denervation, ,1% vs. ,5%; partial denervation,
,2% vs. ,4%) in the EDL. Similarly, we also observed that nearly
all SMND7 NMJs at the end-stage were fully innervated in a wide
range of hindlimb muscles types, including predominantly fast
muscle type (EDL, tibialis anterior),slow muscle type (soleus),mixed
type (gastrocnemius), and the most proximal limb muscle, the
gluteus maximus (Fig. 1C). Moreover, PSCs were co-localized with
over 99% of nerve-muscle contacts in both fast and slow muscle
types examined (Fig. 1A and Fig. S1). We did not observe PSC
sprouting, a feature often seen following denervation [21]. The
innervation pattern was further confirmed with immunocytochem-
istry using antibodies against neurofilament and synaptophysin
(data not shown). As previously reported in various SMA mouse
models [6,8,9,10,22,23], we also observed neurofilament accumu-
lation in the majority of SMND7 NMJs (Fig. S2). In short, our
findings suggest that nearly all NMJs in SMND7 hindlimb muscles
are fully innervated.
Reduced neuromuscular transmission in SMND7
hindlimb muscles
To examine neuromuscular transmission in SMND7 mice, we
performed intracellular recording in EDL muscles at the disease
end-stage (P12–14). Muscle contraction was prevented by pre-
incubation of m-conotoxin, which blocks voltage-gated sodium
channels in muscle [24]. Spontaneous miniature endplate
potentials (MEPPs) and evoked endplate potentials (EPPs) could
be recorded from almost all junctions in both control and SMND7
mice. SMND7 NMJs showed a significantly reduced MEPP
frequency and increased MEPP amplitude (Fig. 2A, 2C and 2D).
The small increase in MEPP amplitude is probably due to the
higher input resistance of the smaller SMND7 muscle fibers.
However, we found that the EPP amplitude was similar between
control and SMND7 NMJs (Fig. 2B and 2E). Correspondingly,
quantal content, calculated by dividing the amplitude of EPP over
MEPP [25], was reduced by about 25% in SMND7 NMJs (Fig. 2F).
The reduced quantal content may have resulted from a decrease
in vesicle release probability, a smaller readily releasable pool
(RRP) or both. We thus subjected the NMJs to paired-pulse and
50 Hz stimulations to examine whether SMND7 NMJs show
differences in release probability and RRP size. There was an
increase in paired-pulse facilitation in SMND7 NMJs (Figs. 3A and
3B), indicating a lower vesicle release probability [26]. Upon
50 Hz stimulation, similar to control NMJs, SMND7 NMJs were
able to sustain repetitive stimulations without any failure (Figs. 3C
and 3D). Although SMND7 NMJs exhibited more facilitated
responses at the beginning of the stimulus train, they depressed to
a similar level as control NMJs. In addition, we calculated the
RRP size using the method by Elmqvist and Quastel [27], and
found a similar RRP size in control and SMND7 NMJs (Fig. 3E).
The probability of release, calculated by dividing the quantal
content of the first EPP by RRP size [28], however, is significantly
lower by 26% at SMND7 NMJs (Fig. 3F). These data suggest the
reduced quantal content in SMND7 hindlimb NMJs is likely due
to a decrease in vesicle release probability, rather than a reduction
of RRP size.
NMJs in SMND7 hindlimb muscles are capable of eliciting
muscle contraction
To address whether the reduced synaptic efficacy at the NMJ
would lead to failures in muscle contraction, we measured muscle
twitch tension in response to the indirect (nerve) and direct
(muscle) stimulation at various frequencies (1, 10, 40, 100 Hz) in
EDL muscles at the disease end-stage (Fig. 4). If the amount of
neurotransmitter release is sufficient to trigger muscle contraction,
the force generated through nerve and muscle stimulation is
expected to be the same and the ratio of indirect/direct
stimulation should be close to one. However, if neuromuscular
transmission failures occur, the ratio would be less than one. As
expected, we found that in control muscle the single twitch tension
(1 Hz, Fig. 4A) as well as the tetanic force (100 Hz, Fig. 4B)
generated by nerve stimulation were similar to those by muscle
stimulation. We found that this was also the case for SMND7
muscle (Fig. 4A and 4B). As quantified in Fig. 4C, the ratio of
indirect over direct stimulation evoked muscle tension was close to
one at all frequencies examined in both control and SMND7 mice.
These results suggest that the overall neuromuscular transmission
is not compromised in SMND7 hindlimb muscles, despite the
reduction by approximately 25% in quantal content.
We did find that SMND7 muscles produced weaker tension
(Fig. 4A and 4B), and had smaller muscle size compared to control
muscles (cross-section area: Control vs. SMND7, 0.4660.02 vs.
0.2360.02 mm
2). To examine whether the reduced force
production can be attributed to the size difference, the specific
force was calculated by normalizing the maximum muscle tension
(by direct muscle stimulation at 100 Hz) to the muscle cross-
section area. We found that the specific force was not significantly
different between control and SMND7 mice (Fig. 4D). These data
suggest that the basic muscle contractile ability may not be
significantly affected and the reduced muscle force was likely
contributed by the smaller muscle size in SMND7 mice.
Loss of central synapses onto L3–5 lateral spinal
motoneurons in SMND7 mice
In addition to the anatomical and functional connectivity of the
NMJ, innervation of motoneurons in the spinal cord is also
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control and reflexes. To explore the possible deficiency in central
synapses contributing to SMA pathology, the number of synapses
on lumbar (L3–5) spinal motoneurons in SMND7 mice at the end-
stage (P12–14) were examined (Fig. 5). We examined only the
motoneurons in the lateral column of these segments, which are
known to innervate hindlimb muscles [29]. Synapses were
fluorescently labeled with anti-synaptophysin antibody and
identified as punctae, and a-motoneurons were identified by size
(.300 mm
2) [30], location and the immunoreactivity of anti-
choline acetyltransferase (ChAT) (Fig. 5A). Quantification of
synapses apposed to the soma and proximal dendrites of the
ChAT-positive motoneurons with nuclei in SMND7 mice as
compared to control revealed an average ,28% reduction in the
number of synapses per motoneuron (Fig. 5B). In order to
minimize the effect of potential size variance of sampled
motoneurons, we calculated the synaptic density by normalizing
the synapse number to unit length of motoneuron perimeter. This
revealed a significant ,21% reduction in SMND7 mice compared
to control mice (Fig. 5C). To exclude the possibility that the
synapse count included synapses on dying cells, the structural
integrity of the SMND7 motoneurons was examined with
hematoxylin and eosin (H&E) staining subsequent to confocal
imaging. Neither necrotic changes (indicated by eosinophilic
cytoplasm) nor apoptotic bodies were associated with the SMND7
motoneurons sampled (Fig. S3).
Figure 1. Fully innervated NMJs in hindlimb muscles of SMND7 mice that express YFP in motoneurons. (A) Z-stacks of confocal
micrographs showing typical NMJs in extensor digitorum longus (EDL) of the SMND7 and control mice at P4, P7 and P14. Nerve terminals
overexpressing YFP (in green), the postsynaptic acetylcholine receptor (AChR) clusters (in red) and the perisynaptic Schwann cells (PSCs; in blue).( B)
Bar graph of the percentage of fully innervated NMJs over total number of endplates at EDL in control and SMND7 mice at P1, P4, P7 and P14. (C)
Histogram showing the percentage of fully innervated NMJs over total number of endplates at P14 hindlimb muscles (GN, gastrocnemius; SOL,
soleus; AT, anterior tibialis; GLU, gluteus maximus). N.300 NMJs in 3–6 animals in each genotype. Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g001
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defect in synaptic formation or maintenance, we examined the
synaptic density on L3–5 spinal motoneurons at earlier develop-
mental stages, P4–P7, when perinatal synaptogenesis continues
[31]. We found that, in SMND7 mice, the synaptic density at both
P4 and P7 were similar to that in control mice (Fig. 5D). However,
unlike control motoneurons, SMND7 motoneurons displayed
synapse loss between P7 and P14. Thus, SMND7 motoneurons
in L3–5 lateral spinal columns are capable of forming new
synapses during early postnatal development, but synapses are not
maintained as the disease progresses.
We also examined synapse loss on SMND7 L3–5 lateral
motoneurons at the electron microscopic level (Fig. 5E). We found
a ,26% reduction in the number of presynaptic terminals onto
motoneurons (identified by size and location) when comparing
Figure 2. SMND7 NMJs display a decrease in synaptic efficacy.
Intracellular recording was performed in EDL muscle at P12–P14. (A)
Sample recordings of MEPP from control (top) and SMND7 (bottom)
mice. (B) Sample recordings of EPP from control (left) and SMND7 (right)
mice. (C–F) Quantifications of the amplitude and frequency of MEPPs
(MEPP amplitude: control 0.6160.03 mV vs. SMND7 0.8260.03 mV,
p,0.0001; MEPP frequency: control 8.9760.99 min
21 vs. SMND7
3.1660.26 min
21, p,0.0001;), EPP amplitude (control 7.2760.34 mV vs.
SMND77 . 5 3 60.31 mV, p =0.58) and quantal content (control
13.2060.77 vs. SMND79 . 9 7 60.45, p=0.007). There is an increase in
MEPP amplitude, a decrease in MEPP frequency and a reduction in
quantal content in SMND7 mice(n=100–130NMJsfrom7 controland10
SMND7 mice; ***p,0.0001, ** p=0.007). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g002
Figure 3. SMND7 NMJs exhibit lower vesicle release probabil-
ity. Intracellular recording was performed in EDL muscle at P12–P14.
(A) Example of paired-pulse response from control (left) and SMND7
(right) NMJs. (B) SMND7 NMJs showed stronger paired-pulse facilitation
indicating a lower vesicle release probability (control 119.463.54% vs.
SMND7 145.9612.5%; p=0.02; n=14 NMJs from 2 control mice and 9
NMJs from 2 SMND7 mice; * p=0.02). (C) Sample traces of high
frequency (50 Hz) stimulation responses from control NMJs (top) and
SMND7 NMJs (bottom). (D) Synaptic responses normalized to the first
EPP. No transmission failure was observed in both control and SMND7
mice. (E) RRP size is not different between control and SMND7 NMJs
(control 640.2677.1 vs. SMND7 625.4654.8, p=0.9). (F) Probability of
release is significantly lower at SMND7 NMJs (control 0.02760.003 vs.
SMND7 0.0260.001, p=0.03; n=15 NMJs from 5 control mice and 14
NMJs from 6 SMND7 mice). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g003
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obtained using confocal microscopy as described above. When we
used a more stringent morphological criterion to define synapses by
quantifying only the presynaptic boutons at juxtaposition to the
electron-dense postsynaptic density (PSD, red asterisks in Fig. 5E), a
more extensive loss of synapses (,50%; Fig. 5G) in SMND7 was
observed. Furthermore, although we found no significant difference
in the presynaptic bouton size between control and SMND7, we did
observe a ,34% reduction in the size of postsynaptic density
relative to the presynaptic bouton size (Fig. S4).
Selective reduction of glutamatergic synapses on L3–5
lateral spinal motoneurons in SMND7 mice
To explore the possible sources of the synapse reduction, we
examined different types of spinal synapses at the end-stage (P12–
14) in SMND7 mice. The number of glutamatergic excitatory
synapses was examined using anti-vesicular glutamate transporters
(VGLUT) 1 and 2 that label the majority of glutamatergic synapses
in the spinal cord [32]. GABAergic inhibitory synapses were
identified with anti-vesicular GABA transporters (VGAT) [33]. We
found that there was an average ,54% reduction in the number of
VGLUT1 synapses onto the soma and proximal dendrites of L3–5
lateral spinal motoneurons in SMND7 mice as compared to control
littermates (Fig. 6A and 6B). In addition to VGLUT1, the number
of VGLUT2-positive synapses also showed a slight but significant
reduction of ,14% onto L3–5 lateral spinal motoneurons in
SMND7 mice(Fig. 6A and 6C).No reductionof eitherVGLUT1 or
VGLUT2 synapses was observed at P7 (Fig. S5). In contrast to
glutamatergic synapses, there was no significant change in the
number of GABAergic synapses onto SMND7 motoneurons at the
end stage (Fig. 6A and Fig. 6D). Taken together, the reduction in
synapses onto SMND7 motoneurons is likely contributed by the
decreased glutamatergic excitatory synapses.
Reduction of proprioceptive sensory neurons in SMND7
mice
It is known that a vast majority of the VGLUT1-positive
synapses abutting onto motoneurons primarily originate from
proprioceptive sensory neurons [32]. To examine whether an
alteration in proprioceptive input from sensory axons is involved in
SMA pathology, the number of proprioceptive dorsal root
ganglion (DRG) cells and their axons was examined in the lumbar
spinal segment (L4) of SMND7 mice at disease end-stage (P12–14).
Fig. 7A shows the gross morphology of a dorsal root from control
and SMND7 mice. We found a slight but significant reduction
(,8%) in the average number of myelinated dorsal root axons in
SMND7 mice compared to that of control littermates (Fig. 7B).
Using an antibody against parvalbumin (PV) as a marker for
proprioceptive DRG cells [34] (Fig. 7C), we found a significant
,13% reduction in the number of proprioceptive DRG cells in L4
spinal segment of SMND7 mice (Fig. 7D).
Increased association of microglia and motoneurons in
the spinal cord of SMND7 mice
Microglia are the resident inflammatory cells in the central
nervous system which could mediate synaptic turnover during
Figure 4. SMND7 NMJs can elicit muscle contraction at disease end-stage. (A) Sample traces of muscle twitch tension measurements at
1 Hz. (B) Sample traces of muscle tetanic force measurements at 100 Hz. In both control (left) and SMND7 (right) EDL muscles, indirect nerve (red)
and direct muscle (black) stimulation elicited similar amounts of muscle force. (C) Quantification of the ratio of indirect over direct stimulation evoked
muscle contraction at 1, 10, 40, 100 Hz. The ratio was close to one at all frequencies examined, indicating overall NMJ function is not compromised in
SMND7 mice (control vs. SMND7: 1 Hz, 0.9760.03 vs. 1.0760.07; 10 Hz, 0.9860.02 vs. 1.0960.08; 40 Hz, 0.9960.04 vs. 1.0360.05; 100 Hz, 1.0260.03
vs. 1.0060.05; n=9 control muscles and 9 SMND7 muscles). (D) Specific force is not significantly different in SMND7 and control mice (control
4.4860.54 g/mm
2 vs. SMND7 4.2360.99 g/mm
2, p=0.84; n=7 control muscles and 8 SMND7 muscles). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g004
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15457Figure 5. Synapses onto L3–5 lateral motoneurons are reduced in SMND7 mice at the end-stage. (A) Confocal micrographs showing the
synapses (labeled with anti-synaptophysin, green) and motoneurons (labeled with anti-ChAT, red) in the ventral horn of the spinal cords of control
and SMND7 mice. (B) Bar graph showing the mean number of synapses on control (64.363.6, n=180 motoneurons) and SMND7 motoneurons
(46.163.7, n=163 motoneurons) (N=10 animals for each genotype; p,0.0001). (C) Bar graph representing the mean number of synapses per
100 mm motoneuron perimeter on control (56.463.2) and SMND7 (44.462.7) motoneurons (p,0.0001). (D) Bar graph showing synaptic density on
motoneurons at P4 (control, 41.465.2, n=64 neurons; SMND7, 45.867.4, n=46 neurons in 3 pairs of animals), P7 (control, 53.964.1, n=48 neurons in
3 animals; SMND7, 53.264.6, n=83 neurons in 5 animals) and P14 (see B). (E) Electron micrograph showing axosomatic synapses on L3–5 lateral
motoneurons in control and SMND7 mice. (F) Bar graphs showing the density of presynaptic terminals on motoneurons (control vs. SMND7: 55.865.8
vs. 40.866.0 boutons per 100 mm perimeter, *p=0.024; Control: n=8 neurons in 4 animals; SMND7: n=11 neurons in 4 animals). (G) Bar graphs
showing the density of synaptic boutons juxtaposed to postsynaptic density (red asterisks in E) (control vs. SMND7: 30.265.7 vs. 14.762.0 boutons
per 100 mm motoneuron perimeter, **p=0.009). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g005
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neuroinflammation (see review [35]). To investigate the involve-
ment of microglia in SMA, we used anti-Iba-1 antibody [36] to
label microglia in the lumbar (L3–5) spinal cord of SMND7 mice
before and after synapse loss (i.e. P4–P14) (Fig. 8). During normal
development, the density of microglia increased perinatally in the
central nervous system (Fig. 8C; also see review [37]). In SMND7
mice, we found a ,34% increase in the density of microglia at P4
and a more profound increase (,65%) at P14 when compared to
control mice (Fig. 8A and 8C). In addition, microglia in SMND7
mice appeared to be activated as demonstrated by their larger cell
body with intense Iba-1 immunoreactivity, and shorter, thicker
processes [35,36] (Fig. 8B). Furthermore, we observed a robust
increase in its physical association with motoneurons in SMND7
lumbar spinal cord at P14 compared to P7 (Fig. 8D and 8E), which
would suggest a possible involvement of microglia-mediated
synaptic stripping [38].
Discussion
The present study investigated the possible involvement of
peripheral and central synaptopathy of the motor circuitry in the
SMND7 mouse model of SMA. We found that nearly all NMJs in
the SMND7 hindlimb muscles were innervated and capable of
neurotransmitter release even at the end-stage when motor
impairment was evident. Despite a modest reduction in synaptic
efficacy in SMND7 NMJs at the end-stage, such a reduction was
not sufficient to cause failure in muscle contraction. In the spinal
cord, we found a significant reduction in glutamatergic central
synapses abutting on the soma and proximal dendrites of SMND7
motoneurons, which was, in part, likely contributed by a loss of
proprioceptive sensory neurons. Furthermore, we showed an
increase in microglia number and association with motoneurons in
SMND7 mice. Our findings provide new insights into the disease
pathology of SMA and may lead to the development of novel
therapeutic strategies that include central synaptic targets.
Synaptic defects at the NMJ do not result in transmission
failure in SMND7 hindlimb muscles
Our morphological findings using both genetically expressed
YFP and immuno-histological staining are consistent with recent
studies showing the majority of NMJs in hindlimb muscles are fully
innervated in SMND7 mice [6,9]. One potential concern is that
the fully innervated NMJs we observed may have resulted from a
delay in synapse elimination, which occurs during the first two
weeks after birth [39]. However, this seems unlikely as synapse
Figure 6. Glutamatergic synapses onto L3–5 lateral motoneurons are reduced in SMND7 mice at the end-stage. (A) Confocal images
showing glutamatergic and GABAergic synapses in the ventral horn of the lumbar spinal cord in control and SMND7 mice. Glutamatergic nerve
terminals were labeled with anti-vesicular glutamate transporter (VGLUT)1 and 2 (green), GABAergic terminals with anti-vesicular GABA transporter
(VGAT; green), and motoneurons with anti-ChAT (red). (B) Bar graph of the number of VGLUT1-positive synapses per 100 mm motoneuron perimeter
on control and SMND7 motoneurons (control 3.160.5 vs. SMND7 1.560.4 boutons per 100 mm motoneuron membrane, n=150 neurons in 5 control
mice and n=127 neurons in 5 SMND7 mice; p,0.0001). (C) Bar graph showing the number of the VGLUT2-positive synapses on control and SMND7
motoneurons (control, 32.164.1, n=100 neurons; SMND7, 27.062.5, n=86 neurons, in 5 animals for each genotype; **p=0.002). (D) Bar graph
representing the number of the VGAT-positive synapses on motoneurons in control and SMND7 mice (control, 32.661.8, n=78 neurons; SMND7,
30.963.1, n=73 neurons, in 3 pairs of animals). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g006
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15457Figure 7. Proprioceptive sensory axons and neurons are reduced in SMND7 mice. (A) Sample pictures showing the cross section of lumbar
4 (L4) dorsal root axons from control and SMND7 mice at P14. (B) Bar graph showing the average number of myelinated dorsal root axons in control
(1707620, n=6) and SMND7 mice (1577627, n=7), *p=0.0032. (C) Micrographs showing proprioceptive neurons immuno-labeled with anti-
parvalbumin (PV) antibody (in green) in the L4 dorsal root ganglion (DRG) of control and SMND7 mice. (D) Bar graph of the total number of PV-
positive cells in L4 DRGs in control (1138627, n=6) and SMND7 (985629, n=4) mice, p,0.0001. Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g007
Figure 8. Microglia associate with lateral motoneurons in SMND7 lumbar (L3–5) spinal cord. (A) Confocal images showing microglia
(labeled with anti-Iba-1, green) and motoneurons (labeled with anti-ChAT, red) in the hemi-section of the lumbar spinal cord of control and SMND7
mice at P14. (B) Magnified views of representative microglia in control and SMND7 lumbar spinal cord at P14. (C) Bar graphs showing the density of
Iba-1-positive cells in the lumbar spinal cord in control and SMND7 mice during development. Control vs. SMND7 (N=4 for each genotype): P4,
49.062.1 vs. 65.564.5 (p=0.048) ; P7, 41.766.6 vs. 58.369.0 (p=0.180); P10, 50.163.2 vs. 82.168.7 (p=0.029); P14, 68.466.1 vs. 112.766.2 (p=0.002).
(D) Confocal images showing microglia (green) and motoneurons (red) in the ventral horn of the lumbar spinal cord of control and SMND7 mice. (E)
Bar graphs showing the percentage of motoneurons associated with microglia at P7 (control 12.460.9% vs. SMND7 12.5616%, N=4 for each
genotype) and P14 (control 11.361.4% vs. SMND7 19.662.2%, N=6 for each genotype; p=0.01). Error bars show s.e.m.
doi:10.1371/journal.pone.0015457.g008
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in hindlimb muscles of SMND7 mice [Lee Y., Mikesh M., Rimer
M., Thompson W. 2007 Society for Neuroscience meeting
abstract. #490.9].
The 25% reduction in quantal release we found in the EDL
muscle is consistent with the 50% decrease observed in another
hindlimb muscle, the tibialis anterior [6], as well as in proximal
muscles, such as transversus abdominis and levator auris longus
muscles [10]. However, since a faithful neuromuscular transmis-
sion is so critical for the survival of an organism, motor nerve
terminals typically release 2 to 20 times more neurotransmitters
than necessary in mice[11]. The functional consequence of the 25
to 50% reduction in synaptic efficacy might thus be negligible as
our twitch tension measurement experiments demonstrated. This
is in agreement with a recent study showing that muscle fibers
could fire normal action potentials in response to nerve stimulation
despite a 50% reduction in quantal release in SMND7 mice [10].
Thus, it seems unlikely that the motor impairment in the hindlimb
muscles of SMND7 mice is simply caused by muscle denervation
or neuromuscular transmission failure. Our twitch tension findings
suggest that the ambulatory difficulties might be in part attributed
to the reduced muscle force production as a result of the smaller
muscle size and possible abnormal muscle development [Lee Y.,
Mikesh M., Rimer M., Thompson W. 2008 Society for
Neuroscience meeting abstract. #752.3] in SMND7 mice.
Although denervation is not observed in hindlimb muscles, it is
important to note that denervation has been found in several
proximal muscles, and would likely contribute to disease
phenotypes seen in SMA patients and mouse models
[6,7,8,17,23]. For example, the intercostal muscles are denervated
in the severe SMA mouse model (Smn
2/2;SMN2
+/+), while the
diaphragm muscle is relatively spared [7]. The denervation in the
intercostal muscles may explain the clinical observations that
breathing is almost entirely diaphragmatic in type I SMA patients
[40]. The reason behind the selective degeneration of motor nerve
terminals in different muscles remains elusive and why and how
muscles show different vulnerability to denervation in SMA would
require further investigation.
Reduction in central synapses in the spinal cord of
SMND7 mice
A loss of central synapses is not uncommon in neurodegener-
ative diseases [41,42]. Concordant evidence of synapse loss was
observed in the ventral horn of autopsied spinal cords from
amyotrophic lateral sclerosis (ALS) patients [43,44,45] and a
mouse model of ALS [14,46]. In studies of autopsied spinal cord
tissues from the SMA Type I patients, a reduction in synapto-
physin-immunoreactivity has also been reported in the ventral
horn of the spinal cord [47,48]. Although the authors concluded
that the synaptophysin-immunoreactivity was preserved in most
surviving motoneurons, no quantitative data was provided in the
studies. Using multiple imaging approaches, we have shown in
SMND7 mice a significant reduction of central synapses,
particularly the proprioceptive inputs, on the lateral motoneurons
in lumbar spinal segments L3–5, which innervate the distal
hindlimb muscles [29]. It is noted that a similar loss in
proprioceptive inputs in L1 spinal segments of SMND7 mice has
also been reported in an abstract recently by Mentis et al. (2008,
Society for Neuroscience meeting abstract. #643.22). Interesting-
ly, the reduction in proprioceptive inputs is not only observed in
SMND7 mice, but also in a new mouse model of SMA [49].
Together, these findings raise the possibility that central synapse
loss plays an important role in the pathogenesis of SMA.
Our data showed that the central synapse loss occurs at a stage
when motoneuron loss is evident in the spinal cord of SMND7
mice [19]. This raises the concern that synapse loss might be
scored on dying motoneurons. To exclude this possibility, we
performed H&E staining subsequent to confocal imaging of
motoneurons to confirm that synapse loss indeed occurs on
surviving SMND7 motoneurons devoid of degenerative features
(Fig. S3). However, the possibility that synapse loss results from
secondary events in response to neurodegeneration, such as gliosis,
cannot be totally ruled out. In fact, we did observe an increase in
microglia population and their association with motoneurons in
SMND7 lumbar spinal segments. This is in line with the idea that
microglia may contribute to the synapse loss through a process
called synaptic stripping – a process in which microglia physically
remove synaptic inputs from CNS neurons in response to insults in
both central [50] and peripheral nervous systems [38]. However,
what triggers the activation of microglia in SMND7 mice would
require further investigation.
Our findings of the reduction of VGLUT1-terminals associated
with the reduction in L4 proprioceptive sensory neurons/axons
suggest that sensory neurons and their afferents are affected by a
deficiency in SMN protein. Indeed, there is evidence that sensory
axons degenerate in SMA Type I patients [51,52,53]. Although
signs of degenerating axons in the dorsal root of the SMND7 mice
were not observed, it is possible that degeneration only occurs at
the distal collaterals of the dorsal root within the spinal cord. In
addition, the reduction in synapses could also be attributed to the
retarded growth of sensory axon terminals as implicated in an in
vitro study of a more severe type of SMA mice (Smn
2/2;SMN2
+/+)
[54]. However, we observed a similar density of VGLUT1
synapses on L3–5 lateral motoneurons in SMND7 mice compared
to that in control mice at P7 (Fig. S5). This suggests that Ia
afferents are able to grow and find their targets in SMND7 mice. It
has been estimated that one single Ia afferent can sprout collaterals
and form over 2700 synapses with up to 300 motoneurons in a
motoneuron pool that innervates the medial gastrocnemius [55].
Therefore, even a relatively modest (,13%) loss of proprioceptive
neurons, as we observed in SMND7 mice, could have a profound
impact on the loss of synapses and function in a large number of
spinal motoneurons.
The current study, like others that study central synapse loss in
injured and diseased nervous systems [12,14,46,56,57,58,59],
focuses only on soma and proximal dendrites. We have not
addressed the possibility that synapses on soma vs. distal dendrites
may display differential vulnerability. For example, selective loss of
VGLUT1 synapse is observed on soma and proximal dendrites
but not on distal dendrites after axotomy [60]. Even though
synapses on the soma and proximal dendrites represent only a
small proportion of all synapses abutting onto motoneurons,
synapses on the somatodendritic membrane strongly influence the
excitability of the motoneurons [61]. Therefore, the loss of
somatodendritic synapses we observed in SMND7 mice may have
functional implications in motoneuron activity as discussed below.
Potential functional implications of central synapse loss
in SMA
Imbalanced neuronal activity has been associated with gluta-
mate excitotoxicity in neurodegenerative diseases such as ALS
[14,62]. The reduction of excitatory synapses may potentially be
neuroprotective, but could also reduce motoneuron activity that
may impair motor control. In particular, we showed that in
SMND7 mice, the most drastic synapse reduction was found in the
sensory-motor connection between proprioceptive sensory neu-
rons and motoneurons. A permanent loss of VGLUT1 synapses in
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stretch reflex response after peripheral nerve injury [60]. This
might explain the abnormality in the sensory reflexes demonstrat-
ed by the abnormal gait, hindlimb splay, and the lack of grasp
response in SMND7 mice [16]. In addition, our finding is in line
with reports that show the monosynaptic stretch reflex (H-reflex) is
either decreased or absent in SMA patients [63,64,65].
The connectivity and functionality of both peripheral and
central synapses are important for transmitting motor commands
from the motor cortex. As discussed above, muscle weakness in
hindlimb muscle is not a direct consequence of neurotransmission
failure, but is likely contributed in part by a reduction in muscle
size in SMND7 mice. In addition, the lack of excitatory signals or
imbalanced excitatory/inhibitory inputs onto motoneurons, as
suggested in this study, may imply reduced excitation of a-
motoneurons in SMA. Indeed, Mentis et al. (2008) have recently
found that SMND7 motoneurons show less synaptic response
upon stimulation of dorsal root afferents and descending fibers
from the thoracic spinal cord [Mentis G.Z., Sumner C.J.,
O’Donovan M.J. 2008 Society for Neuroscience meeting abstract.
#643.22]. A recent study using multi-electrode recording of
motoneurons on the spinal cord slices from another SMA mouse
model (Smn
2/2; SMN2
+/+) also revealed reduced motoneuron
activity [66]. Furthermore, defective synaptic inputs onto moto-
neurons have been shown to disrupt motor circuit activity in a
Drosophila model of SMA [Imlach W., Savner E., Choi B., McCabe
B.D. 2010. 14
th Annual International Spinal Muscular Atrophy
Research Group Meeting hosted by Families of SMA]. Therefore,
central synaptic defects could potentially affect the motoneuron
activity and the motor circuitry, which may explain the deficit in
motor coordination and reflex in SMA. It will be interesting to
investigate whether or not functional changes in central synapses
precede synaptic loss to account for early (,P2) righting defects in
SMND7 mice [16]. Establishing central, in addition to peripheral,
synaptopathy in the mouse model of SMA provides new insights
into understanding SMA pathogenesis and designing treatment
strategies.
Materials and Methods
Ethics Statement
The experimental procedures in this study were conducted in
compliance with the US National Institutes of Health laboratory
animal care guidelines. The protocol was approved by the
Institutional Animal Care and Use Committee of the University
of Southern California (protocol # 11136). All efforts were made
to minimize the suffering of animals.
Animals
Transgenic mice expressing SMA-like phenotypes were gener-
ated from breeder pairs obtained from Jacksons Laboratory
(#5025; FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb
Smn1
tm1Msd). YFP-SMND7 mice were generated by cross-breeding
the aforementioned SMND7 mice with a mouse-line expressing
YFP driven by the Thy-1 promoter [18]. Genotypes of transgenic
mice were determined as described before [18,19]. Transgenic
mice carrying either homozygous/heterozygous mouse Smn alleles
were used as littermate controls.
Immunohistochemistry of NMJs
Mice of the desirable genotype and age were anaesthetized by
intraperitoneal injection of Nembutal (sodium pentobarbital;
50 mg/kg) or ketamine/ xylazine (100 mg/kg ketamine/ 10 mg
xylazine) and transcardially perfused with Ringer’s solution and
then 4% paraformaldehyde. Whole muscles (gastrocnemius,
soleus, tibialis anterior, extensor digitorum longus, gluteus
maximus) were teased into layers of 5–10 fibers thick to facilitate
penetration of antibodies that include: anti-synaptophysin anti-
body (Chemicon, 1:400) for presynaptic nerve terminals, anti-S100
antibody (Dako, 1:200) for Schwann cells and anti-neurofilament
antibody (SMI 312, Covance, 1:1000;). Acetylcholine receptors
(AChRs) were labeled by Alexa Fluor 594-conjugated a-bungaro-
toxin (Invitrogen). Fluorescently labeled NMJs were observed with
epifluorescence or confocal microscopes.
Electrophysiology
The extensor digitorum longus (EDL) muscle from P12–P14
mice was dissected with the sciatic nerve attached. Intracellular
recording was performed in oxygenated normal mammalian
Ringer’s solution (in mM, 135 NaCl, 5 KCl, 1 MgSO4,1 5
NaHCO3,1N a 2HPO4, 11 D-glucose, 2.5 Calcium gluconate,
pH 7.4). Muscle contraction was blocked by pre-incubating the
muscle in 2–3 mM m-conotoxin (Biomol, US) for 45 minutes. The
recording was then performed in the toxin-free Ringer’s solution.
At least 7–10 miniature endplate potentials (MEPPs) and 40–70
evoked endplate potentials (EPPs) were recorded from a given
junction. The EPPs were elicited by 1 Hz train, normalized to
250 mV and corrected for nonlinear summation [67]. The mean
quantal content was calculated by the direct method [25].
Synaptic transmission was also assessed by paired-pulse stimula-
tion (10 ms apart) and high frequency (50 Hz) stimulation. The
size of the readily releasable pool was estimated according to
Elmqvist and Quastel [27]. The quantal content of each EPP in
response to 50 Hz stimulation was plotted against the cumulative
quantal content. The initial linear depression part was fitted with a
linear function and extrapolated to cross the x-axis to obtain an
approximate RRP size. The first EPP was not included in the
linear fitting in both control and SMND7 since both show initial
facilitation. The probability of release was estimated by dividing
the first EPP quantal content by the RRP size [28]. Data was
acquired and analyzed by pClamp8 software and Minialysis
software.
Muscle Twitch tension
Muscle and nerve preparations were placed in Sylgard (Dow
Corning, MI) coated dishes and bathed in normal Ringer’s
solution. The distal end of the muscle was attached to a force
transducer (UC2, Gould-Statham, OH) with a nylon thread.
Muscle contraction was evoked by stimulating the nerve via a
suction electrode (indirect stimulation) or by directly stimulating
the muscle via silver wires (direct stimulation) at 1, 10, 40 and
100 Hz. The direct stimulation was performed with the presence
of d-tubocurarine (1 mM) to block the nerve evoked muscle
contraction. The muscle length was adjusted to maximize the force
produced. The ratio of indirect/direct stimulation evoked muscle
contraction was computed and compared for SMND7 and control
mice.
Light and electron microscopy of the anterior horn spinal
cord
Animals were anesthetized and perfusion-fixed with 4%
paraformaldehyde. Lumbar spinal cord segment (L3–5) were
dissected and processed for cryosections (16 mm-thick). Motoneu-
rons were labeled with anti-choline acetyltransferease (ChAT,
Chemicon) antibody and presynaptic nerve terminals with anti-
synaptophysin. Different excitatory synapses were labeled by anti-
vesicular glutamate transporter 1 and 2 (VGLUT1 and 2)
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by anti-vesicular GABA transporter (vGAT) antibody (Synaptic
System, 1:500). Spinal cord sections were imaged using 1006 oil-
immersion objectives on the Zeiss LSM confocal microscope. All
confocal images were taken using the same imaging parameters
(e.g. laser intensities, amplification gains and offsets). a-motoneu-
rons were identified based on immunoreactivity to ChAT and
location in the ventral horn of the spinal cord. Only large
motoneurons (area.300 mm
2) [30] with clear nuclei were selected
for imaging and quantification. Selected motoneurons were
imaged at optical sections of ,0.7 mm thick showing clear cell
boundaries. Immuno-labeled axosomatic synapses were identified
as boutons apposed to membrane of motoneuron soma and
proximal dendrites (,50 mm from soma) with no visible
intervening space. The number of synaptic boutons around the
motoneuron soma and proximal dendrites (identifiable with
ChAT-immunoreactivity) was manually counted and normalized
to the cell perimeter measured with Image J (NIH imaging
software). To confirm that imaged motoneurons were devoid of
necrotic/ apoptotic features, standard Hematoxylin and Eosin
staining was performed on the same section after confocal
imaging. Motoneurons showing necrotic/ apoptotic features e.g.
eosinophilic cytoplasm, red nucleus, and apoptotic bodies were
excluded in the analyses. For electron microscopy, a-motoneurons
were identified by size (area.300 mm
2) and location in the ventral
horn of the spinal cord. Synapses were identified as boutons
enclosing synaptic vesicles and having electron-dense postsynaptic
density. Synaptic bouton number, apposition length and moto-
neuron perimeter were measured with Image J (NIH imaging
software). To visualize the association of motoneurons with
microglia, cryosections of the lumbar (L3–5) spinal cord were
immuno-labeled with anti-Iba1 antibody (Wako chemical; 1:500)
for microglia and anti-ChAT for motoneurons.
Quantification of proprioceptive dorsal root axons and
ganglion
Dorsal root axons from L4 spinal segment were dissected, post-
fixed in osmium tetroxide and subsequently embedded in Epon.
One mm-thick sections of the axons were stained with toluidine
blue. The number and size of the myelinated axons were counted
using Image J. To examine the number of proprioceptive sensory
neurons, L4 dorsal root ganglion (DRG) were prepared for
cryosections (16 mm-thick). Every fifth serial section was used for
immuno-staining of parvalbumin (PV), a marker for propriocep-
tive sensory neurons [34]. The total number of PV-positive
neurons in each DRG was calculated by multiplying the average
number of PV-positive cells per section to the total number of
sections collected from sectioning through the entire DRG.
Statistical analyses
Data was statistically analyzed using two-tailed Student’s t-tests
with statistic software (Prism 5.0). p,0.05 was considered
significant. Results were expressed as mean 6 s.e.m.
Supporting Information
Figure S1. Perisynaptic Schwann cells are co-localized
with nerve-muscle contacts in both fast and slow muscle
types. The presence of perisynaptic Schwann cells (labeled with
anti-S100 antibody) at NMJ were quantified as ‘‘innervated NMJ’’
in a fast muscle extensor digitorum longus (EDL) and a slow
muscle soleus (SOL) (EDL: Control, 99.460.4%, n=761 NMJs in
3 animals; SMND7 SMA, 99.460.2%, n=484 NMJs in 2
animals; SOL: Control, 99.660.4%, n=675 NMJs in 3 animals;
SMND7 SMA, 95.962.0%, 414 NMJs in 3 animals). (TIF)
Figure S2. Accumulation of neurofilament at the
SMND7 NMJs at the end-stage. Neurofilaments labeled with
anti-neurofilament antibody (in green) was observed in the
majority of nerve terminals at neuromuscular junctions (labeled
with a-bungarotoxin, in red) in the gastrocnemius muscle of
SMND7 mice at P14. (TIF)
Figure S3. SMND7 lateral motoneurons in the L3–L5
spinal segments morphologically resemble control mo-
toneurons. Spinal cord sections of the control and SMA mice
were immuno-stained with anti-synaptophysin (green) for synapses
and anti-ChAT for motoneurons (red) (A & C). After quantifica-
tion of synapses, the same sections were processed with
Hematoxylin and Eosin staining (B & D). SMND7 motoneurons
morphologically resembled control motoneurons and did not show
chromatolytic or apoptotic changes. (TIF)
Figure S4. A size analysis of synapse onto L3–L5 lateral
motoneurons in SMND7 mice at the end-stage. Average
bouton size on L3–L5 lateral motoneurons in control and SMND7
SMA mice are similar despite a ,34% reduction in the size of
postsynaptic density (PSD) normalized to presynaptic bouton size.
(A) Bar graph showing the average bouton size on motoneurons in
control and SMND7 SMA mice (Control, 1.2660.05 mm, n=162
boutons; SMND7, 1.3160.06 mm, n=160 boutons, p=0.46). (B)
Bar graphs showing the percentage of PSD length relative to the
synaptic length (Control, 22.062.0%, n=10 motoneurons;
SMN7, 14.661.9%, n=15 motoneurons; p=0.014). (TIF)
Figure S5. Glutamatergic synapses on SMND7 moto-
neurons in L3–L5 spinal segments are not reduced at P7.
The number of VGLUT1 and VGLUT2 synapses on L3–L5
lateral motoneurons in control and SMND7 mice is similar at P7.
VGLUT1, 5.160.3 (n=65 motoneurons) vs. 5.460.8 (n=30
motoneurons) and VGLUT2, 32.463.2 (n=31 motoneurons) vs.
30.3610.8 (n=36 motoneurons). (TIF)
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